BCYC

BICYCLE THERAPEUTICS PLC

BICYCLE THERAPEUTICS PLC (BCYC) has 6 SEC Form 4 filings (14 transaction rows) in the rolling window, disclosed by 5 distinct insiders. Most recent filing: Jul 7, 2026.

The most active filer is CHIEF PROD & SUPPLY CHAIN OFF Hannay Michael Charles Ferguson with 4 filings.

  • Industry:Biotechnology
  • CEO:Kevin Lee
  • Employees:305
  • HQ:Cambridge, GB
  • IPO:2019-05-23

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$95K

reported sales (SEC code S)

Unique Insiders

5

in the rolling window

Market Cap

$290.0M

latest known value

Source
Sale$4KJul 7SEC ↗
Sale$2KJul 7SEC ↗
Sale$3KJul 7SEC ↗
Sale$448Jul 7SEC ↗
Skynner MichaelFirst filing
Sale$8KJul 7SEC ↗
Skynner MichaelFirst filing
Sale$2KJul 7SEC ↗
Lee KevinFirst filing
Sale$25KJul 7SEC ↗
Lee KevinFirst filing
Sale$7KJul 7SEC ↗
Sale$6KJul 7SEC ↗
Sale$1KJul 7SEC ↗
Sale$19KJan 6SEC ↗
Sale$15KJan 6SEC ↗

Related companies

BICYCLE THERAPEUTICS PLC is in the Healthcare sector.